glp 1 agonists and inflammation GLP-1 Inflammation: How These Drugs Ease Arthritis The Unstoppable Rise of GLP-1

Christensen M, Vedtofte L, Holst JJ, Vilsbll T, Knop FK (2011) Glucose-dependent insulinotropic polypeptide: a bifunctional glucose-dependent regulator of glucagon and insulin secretion in humans

In the HepG2 fatty liver cell model, hypoxia-inducible factor-2alpha (HIF-2)/PPAR pathway was found to be essential for Lira to inhibit liver lipid synthesis and reduce lipid-induced hepatic steatosis [57]

Average weight loss in clinical trials is approximately 5-6% of body weight

Subjects were then dosed for 12 weeks (self-administered at home) with either subcutaneous exenatide 10 g or equivalent volume of placebo twice daily

[Crossref] [PubMed] Avenell A, Robertson C, Skea Z, et al